<DOC>
	<DOCNO>NCT02504177</DOCNO>
	<brief_summary>This study evaluate interruption schedule NOAC patient undergo atrial fibrillation ablation . The investigator compare bleed complication classify major minor bleeding , thromboembolic , vascular complication , Re-admission increase length hospital stay 30-day post-radiofrequency catheter ablation ( RFCA ) period among patient interrupt NOAc 24hours ablation patient stop NOAC morning procedure .</brief_summary>
	<brief_title>Clinical Trial Optimal Novel Oral Anticoagulant ( NOAC ) Schedule Immediate Before Catheter Ablation Atrial Fibrillation</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Anticoagulants</mesh_term>
	<criteria>1 . Patients consent study 2 . Patients Atrial fibrillation ( 2080 year old ) 3. patient undergoing catheter ablation atrial fibrillation due symptomatic , drug refractory atrial fibrillation 4 . Patients possible NOAC 1 . Patients agree study inclusion 2. eGRF &lt; 30ml/min 3 . Impossible NOAC 4 . Structural cardiac disease 5 . Major hemorrhagic complication 6 . CHA2DS2VASc score &gt; 5 7 . Patients experience Ischemic cerebellar infarction 2times</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>